telmisartan has been researched along with Carotid Stenosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, CS; Feng, J; Jiang, F; Qin, X; Tao, T; Wang, T; Zhang, R | 1 |
Fujita, Y; Ihara, M; Ito, H; Kihara, T; Maki, T; Nishio, K; Takahashi, J; Takahashi, R; Tomimoto, H; Washida, K; Wu, X; Yamada, M | 1 |
Zanchetti, A | 1 |
1 review(s) available for telmisartan and Carotid Stenosis
Article | Year |
---|---|
Impact of hypertension and antihypertensive treatment on organ damage.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Carotid Stenosis; Cause of Death; Clinical Trials as Topic; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Survival Rate; Telmisartan; Treatment Outcome | 1999 |
2 other study(ies) available for telmisartan and Carotid Stenosis
Article | Year |
---|---|
Serum Levels of IL-1 β , IL-6, TGF- β , and MMP-9 in Patients Undergoing Carotid Artery Stenting and Regulation of MMP-9 in a New In Vitro Model of THP-1 Cells Activated by Stenting.
Topics: Aged; Benzimidazoles; Benzoates; Carotid Stenosis; Cells, Cultured; Chemokine CCL2; ets-Domain Protein Elk-1; Extracellular Signal-Regulated MAP Kinases; Female; Human Umbilical Vein Endothelial Cells; Humans; Interleukin-1beta; Interleukin-6; Male; Matrix Metalloproteinase 9; Middle Aged; PPAR gamma; Stents; Telmisartan; Transforming Growth Factor beta; Vascular Cell Adhesion Molecule-1 | 2015 |
Nonhypotensive dose of telmisartan attenuates cognitive impairment partially due to peroxisome proliferator-activated receptor-gamma activation in mice with chronic cerebral hypoperfusion.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Anilides; Animals; Benzimidazoles; Benzoates; Carotid Artery, Common; Carotid Stenosis; Cerebral Cortex; Chemokine CCL2; Cognition; Cognition Disorders; Immunohistochemistry; Male; Memory, Short-Term; Mice; Mice, Inbred C57BL; Oligodendroglia; Oxidative Stress; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spatial Behavior; Telmisartan; Tumor Necrosis Factor-alpha | 2010 |